Life Sciences

GSK sets aside $400M for possible settlement

Pharma Compliance Alert, February 4, 2009

GlaxoSmithKline (GSK) is preparing to settle an ongoing investigation into the company’s marketing and promotional practices for nine of its best-selling products between 1997 and 2004.

Post a Comment





Please enter your comment below:


Please enter the text below:


Most Popular